About Novus Diagnostics
Novus Diagnostics is a company based in Dublin (Ireland) founded in 2020.. Novus Diagnostics has raised $7.66 million across 5 funding rounds from investors including Trinity Biotech, Enterprise Ireland and European Union. Novus Diagnostics offers products and services including SepTec™ Technology and Diagnostic Platform. Novus Diagnostics operates in a competitive market with competitors including The Fertility Partners, George Institute, HD, Arialys and Genertec Universal Medical Group, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Novus Diagnostics Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.66 M (USD)
in 5 rounds
-
Latest Funding Round
$2.5 M (USD), Series A
Oct 25, 2024
-
Investors
Trinity Biotech
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Novus Diagnostics
Novus Diagnostics offers a comprehensive portfolio of products and services, including SepTec™ Technology and Diagnostic Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for rapid sepsis detection using sensors and algorithms.
System that provides bedside results for infectious disease classification.
Funding Insights of Novus Diagnostics
Novus Diagnostics has successfully raised a total of $7.66M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $2.5 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $2.5M
-
First Round
First Round
(12 Jan 2021)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Series A - Novus Diagnostics | Valuation |
investors |
|
| Mar, 2023 | Amount | Grant - Novus Diagnostics | Valuation |
investors |
|
| Nov, 2022 | Amount | Series A - Novus Diagnostics | Valuation | Grimpeur Holdings |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Novus Diagnostics
Novus Diagnostics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Trinity Biotech, Enterprise Ireland and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Support is provided to Irish manufacturing and service sector businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Novus Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Novus Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novus Diagnostics Comparisons
Competitors of Novus Diagnostics
Novus Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as The Fertility Partners, George Institute, HD, Arialys and Genertec Universal Medical Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Business consulting services for fertility practices are provided.
|
|
| domain | founded_year | HQ Location |
Medical research is conducted by the institute in health fields.
|
|
| domain | founded_year | HQ Location |
Medical information services are provided in the healthcare sector.
|
|
| domain | founded_year | HQ Location |
Precision medicines for autoimmune neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of medical information solutions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Novus Diagnostics
Frequently Asked Questions about Novus Diagnostics
When was Novus Diagnostics founded?
Novus Diagnostics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Novus Diagnostics located?
Novus Diagnostics is headquartered in Dublin, Ireland.
Who is the current CEO of Novus Diagnostics?
Keith ONeill is the current CEO of Novus Diagnostics.
Is Novus Diagnostics a funded company?
Novus Diagnostics is a funded company, having raised a total of $7.66M across 5 funding rounds to date. The company's 1st funding round was a Series A of $5.16M, raised on Jan 12, 2021.
What does Novus Diagnostics do?
Novus Diagnostics, backed by 13802179.014 from Trinity Biotech, EIC Fund, Enterprise Ireland, European Union, Grimpeur Holdings, focuses on providing healthcare solutions, services for healthcare providers, and medical information providers. Provider of diagnostic information services for clinicians. Driving innovation, growth, and excellence in its industry sectors.
Who are the top competitors of Novus Diagnostics?
Novus Diagnostics's top competitors include George Institute, The Fertility Partners and HD.
What products or services does Novus Diagnostics offer?
Novus Diagnostics offers SepTec™ Technology and Diagnostic Platform.
Who are Novus Diagnostics's investors?
Novus Diagnostics has 5 investors. Key investors include Trinity Biotech, Enterprise Ireland, European Union, EIC Fund, and Grimpeur Holdings.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.